ET.1 State of the art of islet transplantation for treatment of type 1 diabetes as an example of allogeneic therapeutic cell replacement therapy
Thierry Berney, France
14:50 - 15:10
ET.2 Novel strategies in cell therapies for diabetes, beyond conventional immunosuppression
Dr. Giacomo Lanzoni, United States
15:10 - 15:30
ET.3 Preclinical evaluation of niche devices for localized immunomodulation in islet transplantation in patients with type 1 diabetes and applicability of the device in other regenerative medicine fields
Dr. Alessandro Grattoni, United States
15:30 - 15:50
ET.4 Engineering islets for tolerance: A first in human safety study